Breaking News Instant updates and real-time market news.

2020-11-03 07:58:48 NPTN NeoPhotonics $6.69 / -0.115 (-1.69%) 07:58 11/03/20 11/03 07:58 11/03/20 07:58	NeoPhotonics price target raised to $10 from $9 at B. Riley Securities B. Riley Securities analyst Davig Kang raised the firm's price target on NeoPhotonics to $10 from $9 and reiterates a Buy rating on the shares following the company's Q3 results. With Huawei out of the picture, NeoPhotonics' quality of earnings will improve significantly, Kang tells investors in a research note. And with over 40% of sales in 400G+, the company is the best pure optical play, says the analyst.	18 Nov 07 Dec
NPTN NeoPhotonics $6.69 / -0.115 (-1.69%) 10/19/20 Northland Fabrinet upgraded to Outperform following pullback at Northland 10/12/20 B. Riley Securities B. Riley prefers NeoPhotonics, Lumentum in optical component space 10/08/20 JPMorgan NeoPhotonics downgraded to Neutral from Overweight at JPMorgan 10/08/20 JPMorgan NeoPhotonics downgraded to Neutral from Overweight at JPMorgan

2020-11-03 07:58:48

NPTN

NeoPhotonics

$6.69 / -0.115 (-1.69%)

07:58

11/03/20

11/03

07:58

11/03/20

07:58

NeoPhotonics price target raised to $10 from $9 at B. Riley Securities

B. Riley Securities analyst Davig Kang raised the firm's price target on NeoPhotonics to $10 from $9 and reiterates a Buy rating on the shares following the company's Q3 results. With Huawei out of the picture, NeoPhotonics' quality of earnings will improve significantly, Kang tells investors in a research note. And with over 40% of sales in 400G+, the company is the best pure optical play, says the analyst.

18
Nov
07
Dec

NPTN NeoPhotonics

$6.69 / -0.115 (-1.69%)

10/19/20 Northland: Fabrinet upgraded to Outperform following pullback at Northland

10/12/20 B. Riley Securities: B. Riley prefers NeoPhotonics, Lumentum in optical component space

10/08/20 JPMorgan: NeoPhotonics downgraded to Neutral from Overweight at JPMorgan

10/08/20 JPMorgan: NeoPhotonics downgraded to Neutral from Overweight at JPMorgan

TODAY'S FREE FLY STORIES

Recommendations	Laurentian Bank price target raised to C$41 from C$33 at Desjardins » 11:32 03/05/21 03/05 11:32 03/05/21 11:32 LRCDF Laurentian Bank $0.00 / + (+0.00%) Desjardins analyst Doug… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research LRCDF Laurentian Bank $0.00 / + (+0.00%) 02/04/21 Laurentian Bank appoints Sebastien Blair as EVP, CHRO 01/08/21 Laurentian Bank CFO Francois Laurin to retire, Yvan Deschamps to succeed 10/20/20 Laurentian Bank appoints Rania Llewellyn as CEO LRCDF Laurentian Bank $0.00 / + (+0.00%) 03/04/21 Credit Suisse Laurentian Bank price target raised to C$36 from C$30 at Credit Suisse 03/04/21 BMO Capital Laurentian Bank price target raised to C$38 from C$32 at BMO Capital 03/04/21 CIBC Laurentian Bank price target raised to C$37 from C$32 at CIBC 03/04/21 RBC Capital Laurentian Bank price target raised to C$43 from C$33 at RBC Capital
Conference/Events	SM Energy management to meet virtually with KeyBanc » 11:32 03/05/21 03/05 11:32 03/05/21 11:32 SM SM Energy $17.39 / +0.28 (+1.64%) Virtual Meeting to be… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Events SM SM Energy $17.39 / +0.28 (+1.64%) 02/17/21 SM Energy sees 2021 production 47-50 MMBoe 01/13/21 SM Energy falls -9.3% 12/21/20 SM Energy falls -10.7% 10/30/20 SM Energy promotes Herbert Vogel to CEO SM SM Energy $17.39 / +0.28 (+1.64%) 02/22/21 RBC Capital SM Energy price target raised to $18 from $12 at RBC Capital 02/03/21 JPMorgan SM Energy upgraded to Neutral with $13 target at JPMorgan 02/03/21 JPMorgan SM Energy upgraded to Neutral from Underweight at JPMorgan 01/14/21 Barclays SM Energy downgraded to Underweight from Equal Weight at Barclays SM SM Energy $17.39 / +0.28 (+1.64%) 02/17/21 SM Energy reports Q4 adjusted EPS 2c, consensus 5c 02/17/21 SM Energy reports Q4 adjusted EPS 2c, consensus 5c 10/29/20 SM Energy reports Q3 EPS (86c), consensus (28c) 03/09/21 SM Energy 03/09/21 SM Energy
Recommendations	Cominar REIT price target raised to C$9.75 from C$9 at Desjardins » 11:31 03/05/21 03/05 11:31 03/05/21 11:31 CMLEF Cominar REIT $0.00 / + (+0.00%) Desjardins analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research CMLEF Cominar REIT $0.00 / + (+0.00%) 03/04/21 Scotiabank Cominar REIT price target raised to C$10.50 from C$9.75 at Scotiabank 03/04/21 TD Securities Cominar REIT price target raised to C$9.50 from C$9 at TD Securities 11/09/20 RBC Capital Cominar REIT price target raised to C$9 from C$8.50 at RBC Capital 11/06/20 Scotiabank Cominar REIT price target raised to C$9.75 from C$8.75 at Scotiabank
Syndicate	VPC Impact Acquisition Holdings II opens at $10, IPO priced at $10 » 11:31 03/05/21 03/05 11:31 03/05/21 11:31 VPCB VPC Impact Acquisition Holdings II $0.00 / + (+0.00%) VPC Impact Acquisition… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Hot Stocks	Applied UV jumps after subsidiary touts LEDs 'proven to kill' Covid » 11:25 03/05/21 03/05 11:25 03/05/21 11:25 AUVI Applied UV $7.91 / +0.19 (+2.46%) SteriLumen, a wholly… SteriLumen, a wholly owned subsidiary of Applied UV (AUVI), said on Twitter: "The LEDs in our devices have been proven to kill Coronavirus in seconds." Following the tweet, shares of Applied UV jumped 15% to $8.95. In February, SteriLumen acquired Akida, makers of the Airocide product line which was developed with NASA to address air-borne pathogens and bring air purification technology to fight against coronavirus. Reference Link ShowHide Related Items >><< Company News Street Research AUVI Applied UV $7.91 / +0.19 (+2.46%) 02/09/21 Applied UV acquires Airocide technology platform for airborne pathogen reduction 11/09/20 Applied UV signs non-binging LOI to acquire Airocide System 11/05/20 Applied UV subsidiary receives additional Airocide purchase order 11/04/20 Applied UV signs non-binding LOI to acquire the Airocide system AUVI Applied UV $7.91 / +0.19 (+2.46%) 12/17/20 Ladenburg Ladenburg starts infection prevention company Applied UV at Buy 12/17/20 Ladenburg Applied UV initiated with a Buy at Ladenburg

General news	FX Action: USD-JPY » 11:25 03/05/21 03/05 11:25 03/05/21 11:25 FX Action: USD-JPY pulled… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial
Options	21st Century Fox call volume above normal and directionally bullish » 11:25 03/05/21 03/05 11:25 03/05/21 11:25 FOXA Fox Corp. $40.91 / +1.89 (+4.84%) Bullish option flow… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Options FOXA Fox Corp. $40.91 / +1.89 (+4.84%) 02/09/21 Fox Corp. signs Fox News CEO Suzanne Scott to a new multi-year contract 02/09/21 Fox Corp. signs Suzanne Scott to new multi-year contract 02/09/21 Fox Corp. jumps 5% to $34.26 after Q2 results beat expectations 02/09/21 FOX NOW, FOX Nation now available on VIZIO SmartCast platform FOXA Fox Corp. $40.91 / +1.89 (+4.84%) 02/11/21 Citi Fox Corp. price target raised to $33 from $28 at Citi 02/08/21 Morgan Stanley Fox Corp. target raised to $36 at Morgan Stanley after hypothetical LBO exercise 02/08/21 RBC Capital Fox Corp. price target raised to $36 from $31 at RBC Capital 01/28/21 Macquarie Fox Corp. price target raised to $33 from $27 at Macquarie FOXA Fox Corp. $40.91 / +1.89 (+4.84%) 02/09/21 Fox Corp. reports Q2 adjusted EPS 16c, consensus (3c) 02/08/21 Notable companies reporting before tomorrow's open 02/08/21 Notable companies reporting before tomorrow's open 11/03/20 Fox Corp. reports Q1 adjusted EPS $1.18, consensus 74c FOXA Fox Corp. $40.91 / +1.89 (+4.84%) 03/04/21 Fox CEO says no deal with NFL imminent, Bloomberg reports 03/03/21 Amazon in talks to carry 'many' exclusive NFL games on Prime Video, WSJ says 03/03/21 Fox Corp. not exploring go-private deal, CNBC's Faber says 02/09/21 Fox seeks to dismiss Smartmatic's $2.7B defamation lawsuit, NY Times reports FOXA Fox Corp. $40.91 / +1.89 (+4.84%) 12/09/20 Disney upgrade, Zoom Video downgrade among today's top calls on Wall Street 12/04/20 Bet On It: Michigan clears path for online gambling 11/14/20 Week in review: How Trump's policies moved stocks 11/12/20 Fly Intel: Wall Street's top stories for Thursday FOXA Fox Corp. $40.91 / +1.89 (+4.84%) 12/24/20 Early notable gainers among liquid option names on December 24th 12/09/20 21st Century Fox put volume heavy and directionally bearish 11/09/20 21st Century Fox put volume heavy and directionally bearish 11/05/20 21st Century Fox put volume heavy and directionally bearish
Conference/Events	Cowen Internet & restaurants analysts to hold analyst/industry conference call » 11:25 03/05/21 03/05 11:25 03/05/21 11:25 GRUB GrubHub $58.50 / -0.69 (-1.17%) , UBER Uber $51.78 / -1.29 (-2.43%) Internet & New Media… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Syndicate Periodicals On The Fly Events Options GRUB UBER GRUB GrubHub $58.50 / -0.69 (-1.17%) 02/03/21 GrubHub reports Q4 active diners 31.4M, up 39% 01/14/21 GrubHub names Devry Boughner Vorwerk as Chief Corporate Affairs Officer 01/13/21 GrubHub falls -5.5% 01/11/21 Lear partners with GrubHub to deliver ordering capabilities in FCA vehicles UBER Uber $51.78 / -1.29 (-2.43%) 02/26/21 EVgo says partnering to offer savings for EV drivers on Uber's platform 02/19/21 Uber to launch 'nationwide consultation' in UK after Supreme Court ruling 02/19/21 Uber drops 3% to $57.10 after U.K. Supreme Court rejects appeal 02/19/21 U.K. Supreme Court rejects Uber appeal, says drivers are workers GRUB UBER GRUB GrubHub $58.50 / -0.69 (-1.17%) 01/04/21 Barclays GrubHub assumed with an Equal Weight at Barclays 10/16/20 HSBC HSBC upgrades Just Eat Takeaway.com to Buy on continued execution 08/28/20 Piper Sandler Piper 'bearishly inclined' on Uber, Lyft shares into November election 08/13/20 DA Davidson GrubHub price target raised to $79 from $63 at DA Davidson UBER Uber $51.78 / -1.29 (-2.43%) 07:37 Today Citi Uber price target raised to $76 from $60 at Citi 02/22/21 Loop Capital Airbnb upgraded to Buy from Hold at Loop Capital 02/17/21 Argus Uber price target raised to $73 from $63 at Argus 02/16/21 JMP Securities Uber price target raised to $75 from $58 at JMP Securities GRUB UBER GRUB GrubHub $58.50 / -0.69 (-1.17%) 02/03/21 GrubHub reports Q4 adjusted EPS (41c), consensus 5c 02/03/21 Notable companies reporting after market close 10/28/20 GrubHub reports Q3 non-GAAP EPS 16c, consensus (9c) UBER Uber $51.78 / -1.29 (-2.43%) 02/16/21 Tiger Global bought DoorDash and 1Life during Q4, sold out of Alphabet 02/10/21 Uber reports Q4 EPS (54c), consensus (55c) 02/10/21 Notable companies reporting after market close 01/25/21 Fly Intel: What to watch in credit card space earnings reports 08 Jan GRUB UBER GRUB GrubHub $58.50 / -0.69 (-1.17%) 10/27/20 Suit claims Grubhub added eateries to platform without consent, Bloomberg says UBER Uber $51.78 / -1.29 (-2.43%) 03/02/21 Uber spinning out delivery robot operation into startup, Bloomberg reports 02/26/21 Uber-backed Lime in early talks to go public via a SPAC, BI reports 02/24/21 China's Didi Chuxing plans to make debut in Western Europe, Bloomberg says 02/18/21 Uber pushes 'work from home policy' out till mid-September, Tech Crunch reports GRUB UBER GRUB GrubHub $58.50 / -0.69 (-1.17%) 02/03/21 Fly Intel: After-Hours Movers UBER Uber $51.78 / -1.29 (-2.43%) 02/22/21 Airbnb, Snap upgrades among today's top calls on Wall Street 02/12/21 The Intersection: Crypto and Wall Street This Week 02/11/21 Fly Intel: Wall Street's top stories for Thursday 02/11/21 Fly Intel: Wall Street's top stories at midday 12:00 Today Internet & New Media/Restaurants 03/11/21 2021 Consumer, Industrials, & TMT Investor Virtual Conference UBER UBER Uber $51.78 / -1.29 (-2.43%) 02/25/21 Uber call volume above normal and directionally bullish 02/10/21 Uber options imply 11.7% move in share price post-earnings 01/11/21 Uber call volume above normal and directionally bullish 01/07/21 Uber call volume above normal and directionally bullish
Conference/Events	Cowen alternative enery analyst to hold analyst/industry conference call » 11:25 03/05/21 03/05 11:25 03/05/21 11:25 Alternative Energy… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial
Conference/Events	UBS consumer goods analyst to hold an analyst/industry conference call » 11:25 03/05/21 03/05 11:25 03/05/21 11:25 NKE Nike $130.15 / -1.73 (-1.31%) , ADDYY Adidas $0.00 / + (+0.00%) Consumer Goods Analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options NKE ADDYY NKE Nike $130.15 / -1.73 (-1.31%) 03/01/21 Nike head of North America, Ann Hebert, resigns 02/16/21 Third Point buys Upstart, exits Caesars in Q4 02/01/21 Nike announces Nike GO FlyEase hands-free shoe 01/27/21 Columbia Sportswear names Skip Potter as Chief Digital Information Officer ADDYY Adidas $0.00 / + (+0.00%) 02/17/21 Adidas starts divestiture process for Reebok 12/14/20 Adidas assessing strategic alternatives for Reebok, including potential sale 09/24/20 Kanye West demands Gap board seat before product releases 09/10/20 Kohl's launches Adidas active collection with actress Zoe Saldana NKE ADDYY NKE Nike $130.15 / -1.73 (-1.31%) 02/25/21 Fly Intel: Top five analyst upgrades 02/25/21 HSBC Nike upgraded to Buy at HSBC on wider gap relative to competition 02/25/21 HSBC Nike upgraded to Buy from Hold at HSBC 02/05/21 Citi Foot Locker upgraded to Buy from Neutral at Citi ADDYY Adidas $0.00 / + (+0.00%) 03/03/21 Piper Sandler Adidas price target lowered to EUR 284 from EUR 292 at Piper Sandler 02/26/21 RBC Capital Adidas price target raised to EUR 300 from EUR 290 at RBC Capital 02/23/21 Credit Suisse Adidas upgraded to Neutral from Underperform at Credit Suisse 02/11/21 UBS Adidas upgraded to Buy from Neutral at UBS NKE NKE Nike $130.15 / -1.73 (-1.31%) 12/18/20 Nike raises FY21 revenue growth view to low teens 12/18/20 Nike reports Q2 inventories $6.1B, down 2% 12/18/20 Nike reports Q2 NIKE Brand revenue $10.7B, up 8% 12/18/20 Nike reports Q2 NIKE Direct sales $4.3B, up 32% NKE ADDYY NKE Nike $130.15 / -1.73 (-1.31%) 12/02/20 UPS imposes shipping restrictions on Gap, Nike, WSJ reports ADDYY Adidas $0.00 / + (+0.00%) 12/29/20 Reebok's $2.4B price tag brings new buyers to the table, Forbes reports 10/22/20 Adidas said to plan to sell Reebok business, Reuters reports NKE ADDYY NKE Nike $130.15 / -1.73 (-1.31%) 02/09/21 Fly Intel: What to watch in Under Armour earnings report 02/05/21 Citi says buy Foot Locker, sees 'many reasons' why Nike should too 12/21/20 Fly Intel: Wall Street's top stories for Monday 12/21/20 Fly Intel: Wall Street's top stories at midday ADDYY Adidas $0.00 / + (+0.00%) 10/06/20 Beyond Meat boosted by Piper Sandler teen survey results 09/22/20 Fly Intel: What to watch in Nike's earnings report 12:00 Today Consumer Goods 03/10/21 Adidas - ADDYY 03/18/21 Nike - NKE NKE NKE Nike $130.15 / -1.73 (-1.31%) 12/21/20 Early notable gainers among liquid option names on December 21st 12/18/20 Nike options imply 8.7% move in share price post-earnings 11/10/20 Nike call volume above normal and directionally bullish 09/24/20 Unusually active option classes on open September 24th

Conference/Events	Vincera Pharma to host business news update conference call » 11:25 03/05/21 03/05 11:25 03/05/21 11:25 VINC Vincera Pharma $18.00 / -1.17 (-6.10%) Management, along with… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research On The Fly Events VINC Vincera Pharma $18.00 / -1.17 (-6.10%) 03/02/21 Vincera Pharma appoints Hermes Garban as CMO, Hans-Georg Lerchen as CSO 02/24/21 Vincera Pharma to host KOL webinar on VIP152 01/07/21 Vincera Pharma changes name to Vincerx 12/23/20 Vincera Pharma comples business combination with LifeSci Acquisition VINC Vincera Pharma $18.00 / -1.17 (-6.10%) 01/06/21 Chardan Vincera Pharma initiated with a Buy at Chardan VINC Vincera Pharma $18.00 / -1.17 (-6.10%) 09/29/20 Fly Intel: Wall Street's top stories at midday 12:00 Today Vincera Pharma - VINC
Recommendations	Boyd Group Services price target raised to C$250 from C$235 at Desjardins » 11:24 03/05/21 03/05 11:24 03/05/21 11:24 BYDGF Boyd Group Services $0.00 / + (+0.00%) Desjardins analyst David… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research BYDGF Boyd Group Services $0.00 / + (+0.00%) 02/26/21 Stifel Boyd Group Services price target raised to C$250 from C$225 at Stifel 02/19/21 BMO Capital Boyd Group Services price target raised to C$250 from C$249 at BMO Capital 02/16/21 National Bank Boyd Group Services price target raised to C$260 from C$230 at National Bank 02/16/21 National Bank Boyd Group Services upgraded to Outperform from Sector Perform at National Bank
Recommendations	Athabasca Oil price target raised to C$0.40 from C$0.20 at Desjardins » 11:23 03/05/21 03/05 11:23 03/05/21 11:23 ATHOF Athabasca Oil $0.00 / + (+0.00%) Desjardins analyst Justin… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research ATHOF Athabasca Oil $0.00 / + (+0.00%) 12/17/20 RBC Capital Athabasca Oil upgraded to Sector Perform from Underperform at RBC Capital 04/07/20 Scotiabank Athabasca Oil downgraded to Underperform from Sector Perform at Scotiabank 04/03/20 RBC Capital Athabasca Oil price target lowered to C$0.15 from C$0.20 at RBC Capital 03/05/20 TD Securities Athabasca Oil downgraded to Hold from Buy at TD Securities (earlier)
Periodicals	U.S. and EU reach deal to suspend Boeing-Airbus tariffs, Bloomberg says » 11:22 03/05/21 03/05 11:22 03/05/21 11:22 BA Boeing $218.49 / -5.69 (-2.54%) , EADSY Airbus $0.00 / + (+0.00%) The U.S. and EU are said… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options BA EADSY BA Boeing $218.49 / -5.69 (-2.54%) 03/02/21 BAE Systems gets $58M Boeing contract for LRIP of the EPAWSS by USAF 02/26/21 Bell-Boeing awarded $309.58M Navy contract modification 02/24/21 FAA: Pratt & Whitney engines must be inspected before flights resume 02/23/21 Spirit AeroSystems announces backlog of approximately $34B at end of Q4 EADSY Airbus $0.00 / + (+0.00%) 02/26/21 JetBlue takes delivery of first Airbus A321neo featuring reimagined Mint 02/23/21 Spirit AeroSystems announces backlog of approximately $34B at end of Q4 02/18/21 Airbus sees at least EBIT adjusted of EUR2B in 2021 02/17/21 American Airlines sees Q1 system capacity down 45%, may retire more aircraft BA EADSY BA Boeing $218.49 / -5.69 (-2.54%) 09:54 Today Fly Intel: Top five analyst upgrades 09:25 Today Wolfe Research Wolfe upgrades Airlines sector to neutral on 'powerful market forces' 09:04 Today Canaccord Canaccord upgrades Boeing to Buy on travel recovery and MAX return 05:33 Today Canaccord Boeing upgraded to Buy from Hold at Canaccord EADSY Airbus $0.00 / + (+0.00%) 03/04/21 JPMorgan Airbus price target raised to EUR 120 from EUR 107 at JPMorgan 03/04/21 JPMorgan Airbus price target raised to EUR 120 from EUR 107 at JPMorgan 03/01/21 Morgan Stanley Airbus price target lowered to EUR 111 from EUR 112 at Morgan Stanley 03/01/21 Morgan Stanley Boeing price target raised to $250 from $230 at Morgan Stanley BA EADSY BA Boeing $218.49 / -5.69 (-2.54%) 01/27/21 Boeing reports Q4 core EPS ($15.25), consensus ($1.80) 01/26/21 Notable companies reporting before tomorrow's open 01/26/21 Notable companies reporting before tomorrow's open 10/28/20 Boeing reports Q3 core EPS ($1.39), consensus ($2.32) EADSY Airbus $0.00 / + (+0.00%) 02/18/21 Airbus reports FY20 revenue EUR49.9B vs. EUR 70.5B last year 10/29/20 Airbus reports 9-month EPS EUR (3.43) vs. EUR 2.81 last year BA EADSY BA Boeing $218.49 / -5.69 (-2.54%) 08:22 Today Boeing seeking new $4B credit facility from banks, Reuters reports 02/25/21 Boeing facing FAA fine, 'much bigger 787 repair bill,' Reuters says 02/25/21 Boeing facing FAA fine, 'much bigger 787 repair bill,' Reuters says 02/25/21 DOT: FAA must strengthen oversight of aircraft safety, WSJ reports EADSY Airbus $0.00 / + (+0.00%) 02/26/21 Airbus developing hybrid-electric propulsion technology, Reuters reports 02/21/21 Airbus chief urges transatlantic trade war ceasefire, Reuters reports 02/15/21 Lufthansa trying to swap orders to smaller jets, Bloomberg reports 02/11/21 Southwest in talks for at least 300 new 150-seat planes, Air Current says BA EADSY BA Boeing $218.49 / -5.69 (-2.54%) 09:37 Today Boeing upgrade, Nikola downgrade among today's top calls on Wall Street 02/22/21 Fly Intel: Wall Street's top stories for Monday 02/22/21 Fly Intel: Wall Street's top stories at midday 02/22/21 Fly Intel: Pre-market Movers EADSY Airbus $0.00 / + (+0.00%) 01/02/21 Week in review: How Trump's policies moved stocks 12/31/20 Fly Intel: Wall Street's top stories for Thursday 12/31/20 Fly Intel: Wall Street's top stories at midday 11/18/20 Boeing rises after FAA lifts order grounding 737 MAX 04/20/21 Boeing Co. BA BA Boeing $218.49 / -5.69 (-2.54%) 03/04/21 Unusually active option classes on open March 4th 03/03/21 Boeing call volume above normal and directionally bullish 03/03/21 Unusually active option classes on open March 3rd 03/01/21 Early notable gainers among liquid option names on March 1st
Recommendations	Artis REIT price target raised to C$11.50 from C$11 at Desjardins » 11:22 03/05/21 03/05 11:22 03/05/21 11:22 ARESF Artis REIT $0.00 / + (+0.00%) Desjardins analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research ARESF Artis REIT $0.00 / + (+0.00%) 03/04/21 Canaccord Artis REIT price target raised to C$11.85 from C$11.25 at Canaccord 03/04/21 BMO Capital Artis REIT price target raised to C$12.50 from C$12 at BMO Capital 03/04/21 CIBC Artis REIT price target raised to C$12 from C$11.50 at CIBC 03/04/21 TD Securities Artis REIT downgraded to Hold from Buy at TD Securities

Recommendations	NFI Group price target raised to C$35 from C$34 at Scotiabank » 11:19 03/05/21 03/05 11:19 03/05/21 11:19 NFYEF NFI Group $0.00 / + (+0.00%) Scotiabank analyst Mark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research NFYEF NFI Group $0.00 / + (+0.00%) 03/03/21 TD Securities NFI Group price target lowered to C$34 from C$35 at TD Securities 03/02/21 BMO Capital NFI Group price target lowered to C$40 from C$42 at BMO Capital 03/02/21 National Bank NFI Group price target lowered to C$32 from C$33 at National Bank 03/02/21 Stifel NFI Group resumed with a Buy at Stifel
Recommendations	Martinrea price target lowered to C$18.50 from C$19.50 at Scotiabank » 11:18 03/05/21 03/05 11:18 03/05/21 11:18 MRETF Martinrea $0.00 / + (+0.00%) Scotiabank analyst Mark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research MRETF Martinrea $0.00 / + (+0.00%) 11/12/20 Martinrea announces advancements in coated brake lines 11/12/20 NanoXplore announces purchase order from Martinrea for passenger vehicles MRETF Martinrea $0.00 / + (+0.00%) 09:45 Today TD Securities Martinrea downgraded to Hold from Buy at TD Securities 08:51 Today Raymond James Martinrea downgraded to Outperform from Strong Buy at Raymond James 02/03/21 CIBC Martinrea price target raised to C$21 from C$20 at CIBC 01/21/21 Scotiabank Martinrea price target raised to C$19.50 from C$19 at Scotiabank
Recommendations	Labrador Iron Ore Royalty price target raised to C$41 from C$40 at Scotiabank » 11:18 03/05/21 03/05 11:18 03/05/21 11:18 LIFZF Labrador Iron Ore Royalty $0.00 / + (+0.00%) Scotiabank analyst Orest… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research LIFZF Labrador Iron Ore Royalty $0.00 / + (+0.00%) 01/26/21 TD Securities Labrador Iron Ore price target raised to C$40 from C$38 at TD Securities 01/15/21 Raymond James Labrador Iron Ore price target raised to C$38 from C$35 at Raymond James 10/13/20 Scotiabank Labrador Iron Ore price target raised to C$35 from C$33 at Scotiabank 09/24/20 Raymond James Labrador Iron Ore price target raised to C$32 from C$30 at Raymond James
Recommendations	Kinaxis price target lowered to C$179 from C$241 at Scotiabank » 11:17 03/05/21 03/05 11:17 03/05/21 11:17 KXSCF Kinaxis $0.00 / + (+0.00%) Scotiabank analyst Paul… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research KXSCF Kinaxis $0.00 / + (+0.00%) 11:15 Today TD Securities Kinaxis price target lowered to C$165 from C$255 at TD Securities 08:00 Today Stifel Kinaxis upgraded to Buy from Hold at Stifel 11/06/20 RBC Capital Kinaxis price target raised to C$260 from C$240 at RBC Capital 11/06/20 Scotiabank Kinaxis price target lowered to C$241 from C$252 at Scotiabank
Technical Analysis	NASDAQ market internals summary » 11:17 03/05/21 03/05 11:17 03/05/21 11:17 $NSD NASDAQ Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Technical Analysis $NSD NASDAQ Market Internals $0.00 / + (+0.00%) 10:17 Today NASDAQ market internals summary 03/04/21 NASDAQ market internals summary 03/04/21 NASDAQ market internals summary 03/04/21 NASDAQ market internals summary

Hot Stocks	EMA says bamlanivimab can be considered as monotherapy treatment for COVID-19 » 11:16 03/05/21 03/05 11:16 03/05/21 11:16 LLY Eli Lilly $203.63 / +3.06 (+1.53%) The EMA's human… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings Periodicals On The Fly Events Options LLY Eli Lilly $203.63 / +3.06 (+1.53%) 06:48 Today Eli Lilly research and development group publishes pirtobrutinib trial data 03/04/21 Eli Lilly announces results from SURPASS-2 clinical trial 03/03/21 Eli Lilly, Incyte announce BRAVE-AA2 study met primary endpoint 02/26/21 Eli Lilly awarded $210M Army contract for 100,000 doses of antibody therapeutic LLY Eli Lilly $203.63 / +3.06 (+1.53%) 03/02/21 JPMorgan Eli Lilly risk/reward favorable into Alzheimer's data, says JPMorgan 02/18/21 H.C. Wainwright Rigel Pharmaceuticals price target raised to $11 from $8 at H.C. Wainwright 02/18/21 Piper Sandler Rigel share setup 'distinctly positive' after Lilly deal, says Piper Sandler 02/12/21 Cowen Eli Lilly price target raised to $235 from $195 at Cowen LLY Eli Lilly $203.63 / +3.06 (+1.53%) 01/29/21 Eli Lilly backs FY21 EPS view $7.75-$8.40, consensus $8.20 01/29/21 Eli Lilly reports Q4 EPS $2.75, consensus $2.35 01/28/21 Notable companies reporting before tomorrow's open 01/28/21 Notable companies reporting before tomorrow's open LLY Eli Lilly $203.63 / +3.06 (+1.53%) 02/10/21 Eli Lilly won't try to claw back past pay from former CFO Smiley, WSJ reports 12/30/20 Fresenius to administer Lilly, Regeneron COVID antibody drugs, Reuters says 12/23/20 Judge rules against White House drug pricing rule, Reuters says 11/23/20 EU seeks easier access to generic medicines, Reuters says LLY Eli Lilly $203.63 / +3.06 (+1.53%) 02/09/21 Fly Intel: Wall Street's top stories for Tuesday 02/09/21 Fly Intel: Wall Street's top stories at midday 01/29/21 Fly Intel: Wall Street's top stories for Friday 01/29/21 Fly Intel: Wall Street's top stories at midday 00:00 Today Healthcare 03/10/21 Global Healthcare Virtual Conference 2021 03/15/21 Eli Lilly - LLY 04/27/21 Eli Lilly - LLY LLY Eli Lilly $203.63 / +3.06 (+1.53%) 01/15/21 Eli Lilly call volume above normal and directionally bullish 01/13/21 Early notable gainers among liquid option names on January 13th 01/11/21 Early notable gainers among liquid option names on January 11th 12/09/20 Early notable gainers among liquid option names on December 9th
Recommendations	Freehold Royalties price target raised to C$8 from C$7.25 at Scotiabank » 11:16 03/05/21 03/05 11:16 03/05/21 11:16 FRHLF Freehold Royalties $0.00 / + (+0.00%) Scotiabank analyst Jason… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Street Research FRHLF Freehold Royalties $0.00 / + (+0.00%) 11:13 Today TD Securities Freehold Royalties price target raised to C$9.50 from C$9 at TD Securities 02/19/21 National Bank Freehold Royalties price target raised to C$9 from C$7.50 at National Bank 01/14/21 Scotiabank Freehold Royalties price target raised to C$7.25 from C$5.50 at Scotiabank 12/16/20 CIBC Freehold Royalties price target raised to C$8 from C$7 at CIBC
Technical Analysis	NYSE market internals summary » 11:16 03/05/21 03/05 11:16 03/05/21 11:16 $NYE NYSE Market Internals $0.00 / + (+0.00%) Volume is above average… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Technical Analysis $NYE NYSE Market Internals $0.00 / + (+0.00%) 10:16 Today NYSE market internals summary 03/04/21 NYSE market internals summary 03/04/21 NYSE market internals summary 03/04/21 NYSE market internals summary
Recommendations	Bombardier price target raised to C$0.80 from C$0.65 at Scotiabank » 11:16 03/05/21 03/05 11:16 03/05/21 11:16 BDRBF Bombardier $0.00 / + (+0.00%) Scotiabank analyst Konark… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return tomorrow Get Free Trial ShowHide Related Items >><< Company News Street Research Earnings On The Fly Events BDRBF Bombardier $0.00 / + (+0.00%) 03/04/21 Bombardier targets 2025 total revenues about $7.5B 03/04/21 Bombardier expects business jet deliveries to begin gradual recovery in 2021 03/03/21 Bombardier, Aston Martin sign LOI for custom design services on business jets 02/23/21 Bombardier reports suffering 'limited cybersecurity breach' BDRBF Bombardier $0.00 / + (+0.00%) 05:04 Today BMO Capital Bombardier upgraded to Outperform from Market Perform at BMO Capital 02/16/21 Cowen Bombardier downgraded to Underperform from Market Perform at Cowen 02/16/21 Scotiabank Bombardier price target raised to C$0.65 from C$0.55 at Scotiabank 02/12/21 National Bank Bombardier price target lowered to C$0.70 from C$0.80 at National Bank BDRBF Bombardier $0.00 / + (+0.00%) 02/11/21 Bombardier reports Q4 cont ops EPS (1c), consensus 0c 02/11/21 Bombardier sees FY21 adjusted EBITDA greater than $500M BDRBF Bombardier $0.00 / + (+0.00%) 11/13/20 Disney upgrade among today's top calls on Wall Street 05/06/21 Bombardier - BDRBF
Recommendations	Kinaxis price target lowered to C$165 from C$255 at TD Securities » 11:15 03/05/21 03/05 11:15 03/05/21 11:15 KXSCF Kinaxis $0.00 / + (+0.00%) TD Securities analyst… Story temporarily locked. To read stories as they happen please subscribe, Login above, or return in 9 minutes Get Free Trial ShowHide Related Items >><< Street Research KXSCF Kinaxis $0.00 / + (+0.00%) 08:00 Today Stifel Kinaxis upgraded to Buy from Hold at Stifel 11/06/20 RBC Capital Kinaxis price target raised to C$260 from C$240 at RBC Capital 11/06/20 Scotiabank Kinaxis price target lowered to C$241 from C$252 at Scotiabank 10/16/20 CIBC Kinaxis price target raised to C$288 from C$230 at CIBC

Events

Earnings calls, analyst events, roadshows and more

VINC
Today at 12:00

Vincera Pharma - VINC Conference Calls
ENOB
Today at 12:00

Enochian Biosciences Inc Firm Sponsored Meetings
NKE ...
Today at 12:00

Consumer Goods Industry Meetings
Today at 12:00

Alternative Energy Industry Meetings
GRUB ...
Today at 12:00

Internet & New Media/Restaurants Industry Meetings
VTGN
Today at 13:00

VistaGen Therapeutics, Inc. Firm Sponsored Meetings
Today at 13:00

Financials & Fintech Industry Meetings
Today at 13:00

Biotechnology Industry Meetings
Today at 15:00

Fed Reserve Bank President Speaks at Virtual Event Government Event

Virtual Meeting
Today at 15:00

Consumer Credit M/M: January 2021 Government Event

View All Events »

1 of

Syndicate

This week’s upcoming IPOs and secondary offerings

Priced
Not Priced

Mon	SWTX X SWTX SpringsWorks Therapeutics Block Trade Managers: Morgan Stanley Priced at: $84.00 1.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial VRT X VRT Vertiv Holdings Block Trade Managers: JPMorgan Priced at: $20.70 17.4M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial KRTX X KRTX Karuna Therapeutics Secondary Managers: Goldman Sachs & JPMorgan Priced at: $120.00 2.08M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SYNH X SYNH Syneos Health Secondary Managers: Goldman Sachs Priced at: $74.95 7M Shares EAF X EAF GrafTech Spot Secondary Managers: Morgan Stanley Priced at: $11.88 30M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial FRC X FRC First Republic Spot Secondary Managers: BofA, JPMorgan & Morgan Stanley Priced at: $166.50 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HLNE X HLNE Hamilton Lane Spot Secondary Managers: JPMorgan Priced at: $88.25 1.45M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial JELD X JELD Jeld-Wen Spot Secondary Managers: Goldman Sachs Priced at: $29.25 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RCL X RCL Royal Caribbean Spot Secondary Managers: Morgan Stanley Priced at: $91.00 16.938M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SITC X SITC Site Centers Spot Secondary Managers: Morgan Stanley & Wells Fargo Priced at: $13.20 15M Shares WSC X WSC WillScot Mobile Mini Spot Secondary Managers: Morgan Stanley Priced at: $27.20 12.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Tues	OSCR X OSCR Oscar Health IPO Managers: Goldman Sachs, Morgan Stanley & Allen & Co., Wells Fargo, Credit Suisse, BofA, Cowen, LION, Ramirez, SIEB Priced at: $39.00 31M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ASLN X ASLN Aslan Pharmaceuticals Secondary Managers: Jefferies & Piper Sandler Priced at: $4.00 15M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial CDLX X CDLX Cardlytics Secondary Managers: BofA, JPMorgan, Wells Fargo & Raymond James Priced at: $130.00 3.85M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial HSKA X HSKA Heska Secondary Managers: JPMorgan & Piper Sandler Priced at: $186.00 941K Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial INDT X INDT Indus Realty Trust Secondary Managers: Morgan Stanley, Citi & Baird, BTIG, JMP Securities, JPMorgan Priced at: $60.00 1.75M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MORF X MORF Morphic Secondary Managers: Jefferies, Cowen, BMO Capital & RBC Capital Priced at: $70.00 3.5M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ICAD X ICAD iCAD Spot Secondary Managers: Guggenheim Priced at: $18.00 1.222M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial MGY X MGY Magnolia Oil & Gas Spot Secondary Managers: Credit Suisse & Citi Priced at: $10.50 17M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial ORC X ORC Orchid Island Capital Spot Secondary Managers: JPMorgan Priced at: $5.55 8M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial PLXP X PLXP PLx Pharma Spot Secondary Managers: Raymond James & Oppenheimer Priced at: $8.00 7.88M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RDHL X RDHL RedHill Biopharma Spot Secondary Managers: H.C. Wainwright Priced at: $8.00 4.375M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SSYS X SSYS Stratasys Spot Secondary Managers: JPMorgan & Stifel Priced at: $29.00 6.897M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Wed	EYE X EYE National Vision Block Trade Managers: JPMorgan Priced at: $46.50 3.9M Shares INNV X INNV InnovAge IPO Managers: JPMorgan, Barclays, Goldman Sachs & Citi, Baird, William Blair, Piper Sandler, Capital One, Loop Capital, SIEB, Roberts & Ryans Priced at: $21.00 16.667M Shares Special Comments Ratings Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRK X AMRK A-Mark Precious Metals Secondary Managers: DA Davidson & Roth Capital, CIBC Priced at: $28.00 2.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial COHU X COHU Cohu Secondary Managers: Citi, Goldman Sachs & Stifel, B. Riley Securities, Craig-Hallum, DA Davidson Priced at: $41.00 4.95M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DGII X DGII Digi International Secondary Managers: Piper Sandler Priced at: $19.50 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLQT X SLQT SelectQuote Secondary Managers: Credit Suisse, Morgan Stanley, Goldman Sachs, RBC Capital, Barclays, Citi, Evercore ISI & Jefferies, Cantor Fitzgerald, Keefe Bruyette, Piper Sandler, Drexel Hamilton Priced at: $27.50 10.6M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SLRX X SLRX Salarius Pharmaceuticals Secondary Managers: Ladenburg Priced at: $1.3685 14.615M Shares VICI X VICI VICI Properties Secondary Managers: Morgan Stanley, BofA, Citi & Deutsche Bank Priced at: $29.00 60M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial DX X DX Dynex Capital Spot Secondary Managers: JPMorgan & JMP Securities Priced at: $18.35 3.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial LASR X LASR nLight Spot Secondary Managers: Stifel & Raymond James Priced at: $34.00 2.206M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial RADA X RADA Rada Electronic Spot Secondary Managers: Jefferies, Baird & Canaccord, AGPR Priced at: $11.50 4.35M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial STX X STX Seagate Spot Secondary Managers: JPMorgan Priced at: $73.25 4.65M Shares
Thurs	NRIX X NRIX Nurix Therapeutics Secondary Managers: JPMorgan, Piper Sandler & Stifel, RBC Capital, Needham Priced at: $31.00 4.5M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial SUI X SUI Sun Communities Secondary Managers: Citi, BofA, BMO Capital, JPMorgan & RBC Capital Priced at: $140.00 7M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial AMRC X AMRC Ameresco Spot Secondary Managers: BofA & Oppenheimer, Baird, Canaccord, Guggenheim, William Blair Priced at: $44.00 3.2M Shares Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Fri	NCLH X NCLH Norwegian Cruise Line Spot Secondary Managers: Goldman Sachs Priced at: $29.85 47.6M Shares

Mon	No deals
Tues	No deals
Wed	FVRR X FVRR Fiverr Secondary Managers: JPMorgan, Goldman Sachs, Morgan Stanley $279.44 Special Comments Some content is locked. Log in above or sign up for a free trial to see this information. Get Free Trial
Thurs	No deals
Fri	No deals

View All Syndicate Announcements »

NeoPhotonics price target raised to $10 from $9 at B. Riley Securities

TODAY'S FREE FLY STORIES

Get Full Fly Access